Imprimis NJOF, LLC recalls Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for Int
Recalled June 5, 2024 · FDA recall D-0514-2024 · Imprimis NJOF
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
38,060 vials
Sold at
Nationwide within the United States
Description
Lack of Assurance of Sterility
Product
Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01
Manufacturer(s)
Imprimis NJOF, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →